Patient Throughput Articles & Analysis

2013 Trend Report: Magnetic Resonance Imaging Magnetic resonance imaging, or MRI, is a powerful diagnostic tool for today's medical practitioners. New advances in scanner technology are increasing the breadth of MRI's applications at a rapid pace, and the number of scanning suites has exploded in the past decade. Due to the immense technical complexity of MRI systems, these suites can be ...

By KOPP Development Inc.

The US Food and Drug Administration (FDA) has given 510(k) clearance to SpinTech MRI’s latest magnetic resonance imaging software device, STAGE (STrategically Acquired Gradient Echo), a post-processing software platform that enables comprehensive, quantitative brain imaging with enhanced visualization in significantly less time than conventional approaches. STAGE allows MRI ...

By SpinTech, Inc.

Sanofi-backed Enable Injections has gone big with its series C round. Three years after Sanofi led its series B, Enable Injections has raised a $215 million round to fund work on subcutaneous drug delivery system enFuse. Enable Injections’ device consists of a wearable delivery disc and a system for transferring the drug from its original vessel. Users put the disc in the transfer ...

By Enable Injections

To understand the significance of the SpinTech MRI STAGE software platform, it helps to begin by asking a question: Given that MRI is an incredibly powerful diagnostic tool for neurological diseases like Alzheimer’s, dementia, Parkinson’s and multiple sclerosis (MS), why have radiologists and neurologists had to choose between conducting faster MRI exams and obtaining higher-quality ...

By SpinTech, Inc.

Insilico Medicine announced the nomination of a novel preclinical therapeutic candidate for treating COVID-19, designed using the generative chemistry AI platform Chemistry42. The new drug candidate is a 3CL protease inhibitor unique from existing drugs in its class because it can be rapidly produced. While this nomination is a potentially important development for the ongoing COVID-19 pandemic ...

By Insilico Medicine

Both current in vitro and in vivo models used in the development of candidate therapies for the treatment of intestinal diseases have severe limitations. RepliGut®, an in vitro human intestinal epithelial stem cell model, addresses many of these issues and has significant potential to reduce the time and cost of drug development. This model may even help to identify optimal therapies for ...

By Altis Biosystems